Core Insights - The Clorox Company, based in Oakland, California, has a market cap of $12.8 billion and offers a variety of consumer and professional products under well-known brands [1] Performance Overview - Clorox shares have significantly underperformed the broader market, declining 36.4% over the past year, while the S&P 500 Index has increased by nearly 14.1% [2] - Year-to-date in 2025, Clorox stock is down 35.3%, contrasting with the S&P 500's 16.4% rise [2] Comparison with Industry - Clorox's performance is also lagging behind the Consumer Staples Select Sector SPDR Fund, which has only declined about 3.9% over the past year [3] - The ETF's 1.5% dip year-to-date is significantly better than Clorox's double-digit losses [3] Recent Financial Results - On November 3, Clorox reported Q1 results, with an adjusted EPS of $0.85, exceeding Wall Street's expectation of $0.78, and revenue of $1.43 billion, beating forecasts of $1.38 billion [4] - The company anticipates full-year adjusted EPS in the range of $5.95 to $6.30 [4] Future Earnings Expectations - For the fiscal year ending in June 2026, analysts project a 23.5% decline in Clorox's EPS to $5.91 on a diluted basis [5] - Clorox has a mixed earnings surprise history, beating consensus estimates in three of the last four quarters [5] Analyst Ratings - Among 19 analysts covering Clorox stock, the consensus rating is a "Hold," consisting of one "Strong Buy," 13 "Holds," and five "Strong Sells" [5] - The sentiment has become more bearish, with four analysts now suggesting a "Strong Sell" [6] - Nik Modi from RBC Capital maintained a "Hold" rating with a price target of $142, indicating a potential upside of 35.2% from current levels [6]